Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries-Reference-Cited by-同舟云学术

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

Published:2015-10-20 Issue:3 Volume:23 Page:217-226
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Younossi Z.¹,Brown A.²,Buti M.³,Fagiuoli S.⁴,Mauss S.⁵,Rosenberg W.⁶,Serfaty L.⁷,Srivastava A.⁶,Smith N.⁸,Stepanova M.⁹,Beckerman R.⁸

Affiliation:

1. Inova Fairfax Medical Campus; Falls Church VA USA

2. Imperial College Healthcare NHS Trust; London UK

3. Vall d'Hebron University Hospital in Barcelona; Barcelona Spain

4. Ospedale Papa Giovanni XXIII; Bergamo Italy

5. Center for HIV and Hepatogastroenterology; Dusseldorf Germany

6. Division of Medicine; Institute for Liver and Digestive Health; University College London; London UK

7. Hepatology Service; Saint-Antoine Hospital; APHP; INSERM U_936; Pierre&Marie Curie University; Paris France

8. CBPartners; New York City NY USA

9. Center for Outcomes Research in Liver Diseases; Washington DC DC USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12483/fullpdf

Reference51 articles.

1. European Centre for Disease Prevention and Control Health Topics: Hepatitis C http://www.ecdc.europa.eu/en/healthtopics/hepatitis_C/Pages/index.aspx

2. Europe WHOROf Hepatitis: Data and Statistics http://www.euro.who.int/en/health-topics/communicable-diseases/hepatitis/data-and-statistics

3. Epidemiology of hepatitis C virus (HCV) infection;Sy;Int J Med Sci,2006

4. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals;PharmacoEconomics - Open;2023-12-15

2. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease;Clinics in Liver Disease;2023-05

3. Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain;PLOS ONE;2022-12-01

4. Hepatitis C: Standard of Treatment and What to Do for Global Elimination;Viruses;2022-02-28

5. Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study;The Lancet Regional Health - Western Pacific;2022-01